Infusion Pump Market Worth $7 Billion in 2015

The global market for infusion medical pumps grew at an average rate of 2.6% from $6.1 billion in 2010 to almost $7 billion in 2015. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Infusion pumps are used to provide necessary fluids, basic fluids for hydration as well as pain medications, antibiotics, or chemotherapy, to a patient’s circulatory system. They are mostly used in emergency departments, operating rooms, and neonate departments of hospitals, long-term care settings, physician’s offices, and home settings when continuous monitoring and treatment is expensive, impractical, or unreliable.

Medical infusion pumps are divided in six categories, namely large volume infusion pumps, ambulatory infusion pumps, syringe infusion pumps, insulin infusion pumps, implantable infusion pumps, and enteral feeding pumps. Large volume infusion pumps are used for delivery of nutrients and hydration products to patients, while ambulatory infusion pumps are commonly used in hospital, surgical, home and emergency medical facilities. Syringe pumps are used for the delivery of precise amounts of fluid and drugs to patients, while insulin infusion pumps are employed for diabetes management in patients. Implantable infusion pumps are used for specific drugs, dosages, and routes of administration, while enteral feeding pumps are uses to provide liquid nutrition into the digestive system.

“Some areas of the market continue to display strong growth, including insulin infusion pumps and ambulatory enteral feeding pumps,” said Bruce Carlson, Publisher of Kalorama Information. “Each segments of the infusion pumps market has shown an increase, each segment experiencing a range of market drivers.”

“Smart” pump technologies and other advanced features have become a key driver of the infusion pump market. A smart pump is equipped with intravenous (IV) medication error-prevention software to alert operators when a pump setting is programmed outside of pre-configured limits. This, coupled with the growth in wireless capabilities, and advanced connectivity and integration is driving end users to evaluate device inventory and integrate advanced devices.

Some of the leading competitors and niche product developers include Baxter (Baxter, Deerfield, IL, USA), B. Braun (Melsungen, Germany), Halyard Health (Alpharetta, GA, USA), Johnson & Johnson (J&J, New Brunswick, NJ, USA), Medtronic (Dublin, Ireland), and Roche (Basel, Switzerland).

Related Links:
Kalorama Information
Baxter
Johnson & Johnson
Roche